pTVG-HP DNA Vaccine With or Without pTVG-AR DNA Vaccine and Pembrolizumab in Patients With Castration-Resistant, Metastatic Prostate Cancer

Conditions:   Castration-resistant Prostate Cancer;   Metastatic Cancer;   Prostate Cancer Interventions:   Biological: pTVG-HP;   Biological: pTVG-AR;   Drug: Pembrolizumab;   Drug: rhGM-CSF Sponsors:   University of Wisconsin, Madison;   Merck Sharp & Dohme Corp.;   Madison Vaccines, Inc;   Prostate Cancer Foundation Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials